We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Non-Insulin Diabetes Drugs Mask Surgical Ketoacidosis

By HospiMedica International staff writers
Posted on 31 Jul 2019
A new study warns that sodium-glucose co-transporter-2 inhibitors (SGLT2i) can lead to dangerous undetected ketoacidosis in diabetics during surgery, as their blood sugar level remains normal.

Researchers at Queen Elizabeth Hospital (Adelaide, Australia) and the University of Adelaide (UA; Australia) searched PubMed, Embase, and ProQuest for clinical reports of perioperative diabetic ketoacidosis (DKA) with near-normal blood glucose concentrations, termed euglycaemic ketoacidosis (EDKA), involving SGLT2i medications up to January 2019. More...
In all, 42 cases of EDKA and five cases of hyperglycaemic diabetic ketoacidosis (HDKA) were reported.

The SGLT2i Canagliflozin was implicated in 26 cases, with presentation time varying from a few hours up to six weeks after surgery. Precipitating factors included medication changes, diet modifications, and intercurrent illnesses. Thirteen of the cases (12 EDKA, one HDKA) involved bariatric surgery, with 10 of these patients noted very-low-calorie diet regimes as a precipitating factor. Seven patients required mechanical ventilation, and acute kidney injury (AKI) was noted in five. Outcome data were available in 32 cases, all of them recovered completely. The study was published in the July 2019 issue of the British Journal of Anaesthesia.

“Euglycaemic ketoacidosis can happen in people with both type 1 and type 2 diabetes. Unless special tests are done to assess the acid load in the body, clinicians can miss this complication. The symptoms are similar to other events during and after surgery such as mild acid build up, vomiting, and abdominal pain,” said lead author Venkatesan Thiru, MD. “Euglycaemic ketoacidosis is deceiving and likely to be missed easily as it presents with near or low-normal blood sugars.”

“Gliflozin medications are being increasingly used to protect people against heart and kidneys diseases. They work in the kidneys to excrete excess sugar in diabetic patients’ urine. The condition may happen in the lead-up to surgery when patients cannot eat and drink normally,” concluded Dr. Thiru. “Patients who undertake weight reduction surgery when they are on a special diet program are at an increased risk of experiencing this complication. Extra vigilance is the key, and patients should be educated about this. Caregivers should ask for acid load to be tested by checking for blood ketone levels.”

DKA arises because of a lack of insulin in the body, which leads to an increased release of glucose by the liver via glycogenolysis and gluconeogenesis. The high glucose levels spill over into the urine, taking water and minerals along with it, in a process known as osmotic diuresis. This leads to the release of free fatty acids from adipose tissue, which are converted through beta oxidation into ketone bodies. The ketone bodies, in turn, cause the blood to turn acidic (metabolic acidosis), which can lead to serious consequences, including coma and death.

Related Links:
Queen Elizabeth Hospital
University of Adelaide


Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Digital Radiography System (Ceiling Free)
Digix CF Series
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image: The findings suggest that hematopoietic cell transplantation may benefit patients with Shwachman-Diamond syndrome soon after high-risk features are detected, before advanced malignancy develops. (Image Credit: Shutterstock)

Early Stem Cell Transplantation May Improve Survival in Rare Inherited Bone Marrow Disorder

Shwachman-Diamond syndrome (SDS) is a rare inherited bone marrow disorder that can progress to severe hematologic disease. More than 90% of affected children survive beyond age 20, but fewer than 30% live... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.